Skip to main content

Table 1 Baseline characteristics

From: Cardiovascular magnetic resonance feature tracking for characterization of patients with heart failure with preserved ejection fraction: correlation of global longitudinal strain with invasive diastolic functional indices

 

HFpEF (n = 18)

Healthy Controls (n = 18)

p

Age (years)

65 ± 17

61 ± 14

0.414

Male

3 (16.7)

7 (38.9)

0.137

BMI (kg/m2)

25.8 ± 6.7

22.7 ± 3.9

0.098

BNP (pg/mL)

178 ± 319

n/a

n/a

NYHA I

0 (0)

18 (100)

< 0.0001

NYHA II

11 (61.1)

0 (0)

0.0002

NYHA III

6 (33.3)

0 (0)

0.013

NYHA IV

1 (5.6)

0 (0)

0.473

Smoker

5 (27.8)

4 (22.2)

0.700

Hypertension

15 (83.3)

0 (0)

< 0.001

Dyslipidemia

8 (44.4)

5 (27.8)

0.298

Diabetes

2 (11.1)

0 (0)

0.488

Beta-blocker

8 (44.4)

1 (5.6)

0.070

ACE/ARB

12 (66.7)

0 (0)

< 0.001

Calcium channel blocker

8 (44.4)

0 (0)

0.003

Diuretics

8 (44.4)

0 (0)

0.003

Statins

3 (16.7)

3 (16.7)

1.000

  1. BMI Body mass index, BNP Brain natriuretic peptide, NYHA New York Heart Association, ACE Angiotensin converting enzyme inhibitor, ARB Angiotensin receptor blocker